P280 Identification of factors associated with the participation in an adjuvant treatment clinical study for patients with breast cancer
Sala, R, Dodyk, P, Varela, M, Lerzo, G, Blajman, C, Zarba, J, Lacava, J, Alvarez, A, Richardet, E, Fein, L
Published in Breast (Edinburgh) (2011)
Published in Breast (Edinburgh) (2011)
Get full text
Journal Article
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Socinski, Mark A, Jotte, Robert M, Cappuzzo, Federico, Orlandi, Francisco, Stroyakovskiy, Daniil, Nogami, Naoyuki, Rodríguez-Abreu, Delvys, Moro-Sibilot, Denis, Thomas, Christian A, Barlesi, Fabrice, Finley, Gene, Kelsch, Claudia, Lee, Anthony, Coleman, Shelley, Deng, Yu, Shen, Yijing, Kowanetz, Marcin, Lopez-Chavez, Ariel, Sandler, Alan, Reck, Martin
Published in The New England journal of medicine (14.06.2018)
Published in The New England journal of medicine (14.06.2018)
Get full text
Journal Article
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study
Martín, Miguel, Lim, Elgene, Chavez-MacGregor, Mariana, Bardia, Aditya, Wu, Jiong, Zhang, Qingyuan, Nowecki, Zbigniew, Cruz, Felipe Melo, Safin, Rustem, Kim, Sung-Bae, Schem, Christian, Montero, Alberto J, Khan, Sarah, Bandyopadhyay, Reeti, Moore, Heather M, Shivhare, Mahesh, Patre, Monika, Martinalbo, Jorge, Roncoroni, Laura, Pérez-Moreno, Pablo Diego, Sohn, Joohyuk
Published in Journal of clinical oncology (20.06.2024)
Published in Journal of clinical oncology (20.06.2024)
Get full text
Journal Article
3055 POSTER Cetuximab plus irinotecan in patients (pts) with metastatic colorectal cancer (mCRC) progressing on or after prior irinotecan therapy: final results of the LABEL study
de Cerqueira Mathias, C, Perazzo, F, Simon, S, Fein, L, Hidalgo, J, Murad, A.M, Lerzo, G, Esser, R, Scheid, S, Buzaid, A.C
Published in European journal of cancer supplements (2007)
Published in European journal of cancer supplements (2007)
Get full text
Journal Article
Abstract P4-13-12: Everolimus plus trastuzumab and vinorelbine for trastuzumab-resistant, taxane-pretreated, HER2+ advanced breast cancer: Overall survival results from BOLERO-3
Isaacs, C, O'Regan, R, Xu, B, Masuda, N, Arena, F, Yap, Y-S, Papai, Z, Lang, I, Armstrong, A, Lerzo, G, White, M, Shen, K, Zhang, Y, Jappe, A, Pacaud, LB, Taran, T, Ozguroglu, M
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P4-22-13: Everolimus plus trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: Overall survival results from BOLERO-1
Yardley, D, Hurvitz, S, Jiang, Z-f, Toi, M, Burris, H, Buyse, M, Slamon, D, Makhson, A, Elsaid, A, Lerzo, G, Hellerstedt, B, Nuzzo, F, Sohn, J, Manzyuk, L, Cabaribere, D, Lincy, J, Weimann, A, Noel-Baron, F, Pacaud, L, Andre, F
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
11 Flabra, frontline approach for BRCA testing in ovarian cancer (OC) treatment naïve population. A latin america (LA) epidemiologic study
Goncalves, S, Gomez Abuin, G, Gallardo, D, Estevez Diz, P, Caceres, V, De la Vega, M, Palazzo, F, Lerzo, G, Kaen, D, Gerson, R, Lim, M, Philco, M, Moreira Costa Zorzzeto, M, De Melo, AC, Hegg, R, de Oliveira Santana, R, Medeiros Milhomen Beato, P, Trujillo, L, Plata, M, Yepes, A, Cock, A, Bonifacino, MM, Cortes, M, Fein, L, Castillo, C, Pacheco, C, Ticona, M, Hoyoa, E, Jaramillo, R, Soare Nunes, J, Menezes Morelle, A, Freire de Carvalho Calabrich, A, Cronemberger Costa e Silva, EH, Mora, P, Damian, F, Diaz Perez, I, Sganga, L, Pereira, MH, Ramirez, H, Nogueira, A, Guindalini, R, Miranda, V, Giornelli, G
Published in International journal of gynecological cancer (01.09.2019)
Published in International journal of gynecological cancer (01.09.2019)
Get full text
Journal Article
Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain
Radbruch, Lukas, Torres, Luis M., Ellershaw, John E., Gatti, Antonio, Luis Lerzo, Guillermo, Revnic, Julia, Taylor, Donald
Published in Supportive care in cancer (01.03.2012)
Published in Supportive care in cancer (01.03.2012)
Get full text
Journal Article
Abstract P4-12-26: A phase II randomized study of lapatinib in combination with capecitabine, vinorelbine or gemcitabine as first or second line-therapy in patients with HER2 positive metastatic breast cancer progressing after taxane (LACOG 0801)
Gomez, H, Neciosup, S, Tosello, C, Mano, M, Bines, J, Ismael, G, Santi, PX, Pinczowsky, H, Neron, Y, Fanelli, M, Fein, L, Sampaio, C, Lerzo, G, Capo, A, Zarba, JJ, Blajman, C, Varela, MS, Martínez-Mesa, J, Werutsky, G, Barrios, CH
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
Ixabepilone plus capecitabine vs capecitabine in patients with triple negative tumors: a pooled analysis of patients from two large phase III clinical studies
Rugo, HS, Roche, H, Thomas, E, Blackwell, K, Chung, H, Lerzo, G, Volles, LA, Poulart, V, Perez, E
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Published in Cancer research (Chicago, Ill.) (15.01.2009)
Get full text
Journal Article
Preliminary data from a phase II study of cetuximab with irinotecan in heavily pretreated patients with epidermal growth factor (EGFR)-expressing metastatic colorectal cancer (mCRC): LABEL
Buzaid, A., de Cerqueira Mathias, C., Perazzo, F., Simon, S., Fein, L., Hidalgo, J., Murad, A. M., Esser, R., Loos, A., Lerzo, G.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Phase II trial of ixabepilone in patients with metastatic breast cancer (MBC) who are resistant to an anthracycline, a taxane and capecitabine
Thomas, E., Perez, E. A., Mukhopadhyay, P., Lerzo, G., Pivot, X., Bosserman, L. D., Mullaney, B., Vahdat, L., Hortobagyi, G. N.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Gemcitabine (GEM) + oxaliplatin (OX) in patients (pts) with stage III/IV ovarian cancer following 3 cycles of carboplatin (CB) + paclitaxel (PAC): Preliminary report of a phase II study
Arca, R., Ibarra, J., Lerzo, G., Mandachain, M., Mickievicz, E., Perez, J., Richardet, E., Rodger, J., Van Kooten, M., Orlando, M.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Gemcitabine (GEM) + oxaliplatin (OX) in patients (pts) with stage III/IV ovarian cancer following 3 cycles of carboplatin (CB) + paclitaxel (PAC): Preliminary report of a phase II study
Arca, R., Ibarra, J., Lerzo, G., Mandachain, M., Mickievicz, E., Perez, J., Richardet, E., Rodger, J., Van Kooten, M., Orlando, M.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Uracil/tegafur plus oral calcium folinate in advanced breast cancer
Richardet, E, Pedraza, C, Mickiewicz, E, Lerzo, G, Bonamasa, M, Coppola, F, Elli, A, Uranga, G, Jovtis, S, Bruno, M, Ventriglia, M, Cuevas, M A, Alvarez, A M, Suarez, L A, Fein, L
Published in Oncology (Williston Park, N.Y.) (01.07.1999)
Get more information
Published in Oncology (Williston Park, N.Y.) (01.07.1999)
Journal Article